[go: up one dir, main page]

FR2732601B1 - Utilisation d'un sel de metal alcalino-terreux pour le traitement des rougeurs cutanees d'origine neurogene - Google Patents

Utilisation d'un sel de metal alcalino-terreux pour le traitement des rougeurs cutanees d'origine neurogene

Info

Publication number
FR2732601B1
FR2732601B1 FR9504267A FR9504267A FR2732601B1 FR 2732601 B1 FR2732601 B1 FR 2732601B1 FR 9504267 A FR9504267 A FR 9504267A FR 9504267 A FR9504267 A FR 9504267A FR 2732601 B1 FR2732601 B1 FR 2732601B1
Authority
FR
France
Prior art keywords
alkalino
rednesses
skin
treatment
earth metal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9504267A
Other languages
English (en)
Other versions
FR2732601A1 (fr
Inventor
Lacharriere Olivier De
Lionel Breton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR9504267A priority Critical patent/FR2732601B1/fr
Priority to EP96400513A priority patent/EP0737471A3/fr
Priority to NO19961371A priority patent/NO323573B1/no
Priority to CA002173689A priority patent/CA2173689C/fr
Priority to US08/630,326 priority patent/US5851556A/en
Publication of FR2732601A1 publication Critical patent/FR2732601A1/fr
Application granted granted Critical
Publication of FR2732601B1 publication Critical patent/FR2732601B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/005Preparations for sensitive skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9504267A 1995-04-10 1995-04-10 Utilisation d'un sel de metal alcalino-terreux pour le traitement des rougeurs cutanees d'origine neurogene Expired - Fee Related FR2732601B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR9504267A FR2732601B1 (fr) 1995-04-10 1995-04-10 Utilisation d'un sel de metal alcalino-terreux pour le traitement des rougeurs cutanees d'origine neurogene
EP96400513A EP0737471A3 (fr) 1995-04-10 1996-03-12 Utilisation d'un sel d'une métal alcalino-terreux comme inhibiteur de TNF-alpha dans une composition unique et composition obtenue
NO19961371A NO323573B1 (no) 1995-04-10 1996-04-03 Preparat inneholdende minst ett strontiumsalt, et aktivt middel, og minst ett middel valgt fra et hydrofilt middel og/eller et lipofilt middel og/eller et termal- eller mineralvann.
CA002173689A CA2173689C (fr) 1995-04-10 1996-04-09 Utilisation d'un sel d'un metal alcalino-terreux comme inhibiteur de tnf-.alpha. ou de substance p dans une composition topique et composition obtenue
US08/630,326 US5851556A (en) 1995-04-10 1996-04-10 Use of a salt of an alkaline-earth metal as TNF-A or substance P inhibitor in a topical composition and composition obtained

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9504267A FR2732601B1 (fr) 1995-04-10 1995-04-10 Utilisation d'un sel de metal alcalino-terreux pour le traitement des rougeurs cutanees d'origine neurogene

Publications (2)

Publication Number Publication Date
FR2732601A1 FR2732601A1 (fr) 1996-10-11
FR2732601B1 true FR2732601B1 (fr) 1997-05-09

Family

ID=9477949

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9504267A Expired - Fee Related FR2732601B1 (fr) 1995-04-10 1995-04-10 Utilisation d'un sel de metal alcalino-terreux pour le traitement des rougeurs cutanees d'origine neurogene

Country Status (1)

Country Link
FR (1) FR2732601B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007060381A1 (fr) * 2005-11-24 2007-05-31 Santosolve As Préparations contenant du strontium et leur application à des méthodes de traitement cosmétique

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE35991B1 (en) * 1971-01-22 1976-07-21 Comprehensive Pharmaceuticals Improvements in or relating to the treatment of diseases of the skin and mucosa
EP0217975B1 (fr) * 1985-10-08 1991-12-04 Psori-Med Ag Mélange de sels pour le traitement du psoriasis et autres maladies de la peau
US5296476A (en) * 1989-09-08 1994-03-22 Henderson Esther G Skin care compositions
JPH0710720A (ja) * 1993-06-25 1995-01-13 Tomihiko Yamada 表皮及び毛髪の水溶性保護剤並びに水溶性外用剤

Also Published As

Publication number Publication date
FR2732601A1 (fr) 1996-10-11

Similar Documents

Publication Publication Date Title
FR12C0077I2 (fr) Composition pour le traitement des condylomes génitaux
FR2714829B1 (fr) Composition cosmétique et/ou dermatologique pour le traitement du vieillissement contenant des céramides, son utilisation.
FR2672306B1 (fr) Solutions perfectionnees de zincate pour le traitement de l'aluminium et des alliages d'aluminium.
FR2659551B1 (fr) Composition cosmetique liquide contenant de la silice pour l'etirement des rides de la peau.
FR2663044B1 (fr) Appareil pour le traitement de surfaces.
FR2779639B1 (fr) Composition cosmetique contenant un polyorganosiloxane et un terpolymere acrylique et utilisation de cette composition pour le traitement des matieres keratiniques
EP0771563A3 (fr) Utilisation des ligandes de recepteur 5-HT1A pour le traitement du glaucome
EP0639076A4 (fr) Utilisation d'inhibiteurs de guanylate cyclase dans le traitement des etats de choc.
FR2779638B1 (fr) Composition cosmetique contenant un polysaccharide et un terpolymere acrylique et utilisation de cette composition pour le traitement des matieres keratiniques
MA24332A1 (fr) Utilisation de 1-hydroxy-2- pyridones pour le traitement d'infections de la peau
FR2741262B1 (fr) Utilisation d'un antagoniste de tnf-alpha pour le traitement des rougeurs cutanees d'origine neurogene
FR2567762B1 (fr) Dispositif pour le traitement esthetique de la peau
FR2732598B1 (fr) Utilisation de sel de metaux alcalino-terreux pour le traitement des prurits et des dysesthesies oculaires ou palpebraux
EP0674026A3 (fr) Appareillage pour traitement électrolytique.
FR2758465B1 (fr) Composition pour le traitement de l'amiante
EP0860867A4 (fr) Traitement de surface pour micro-usinage
FR2781504B1 (fr) Foulon pour le traitement des cuirs, peaux et similaires
DE69407992D1 (de) Kompakte pfanne zur behandlung von metallschmelze
FR2732601B1 (fr) Utilisation d'un sel de metal alcalino-terreux pour le traitement des rougeurs cutanees d'origine neurogene
MA23837A1 (fr) Benzamides pour le traitement de degenerescenses neurologiques
DE69302799D1 (de) Zusammensetzung für die Behandlung von Kesselwasser
FR2782007B1 (fr) Utilisation des calix(n)arenes pour le traitement des maladies fibrotiques
EP0859761A4 (fr) 4-azasteroides utilises pour le traitement d'etats hyperandrogeniques
DZ3320A1 (fr) Complexe comprenant de l'eletriptane et de la sulphobutylether-cyclodextrine pour le traitement de la migraine
EP0687470A3 (fr) Agents pour le traitement des maladies métaboliques des os

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20091231